Having trouble accessing articles? Reset your cache.

Narrowing down graft stenosis

One of the dominant problems after coronary artery bypass graft surgery is hyperplastic growth inside the transplanted blood vessel that can lead to stenosis. Now, a team at the NIH's National Heart, Lung, and Blood Institute has found that this hyperplasia is rooted in a change in the phenotype of endothelial cells lining the transplanted veins and has shown that blocking transforming growth factor-b activity in mice can significantly slow the cellular changes.1

Next, the team will try to replicate the findings using transplant models in pigs and will investigate the transforming growth factor-b (TGFB; TGFb) pathway for other points of intervention that could represent therapeutic targets.

Cellular changes are a fundamental part of the vascular remodeling process after coronary artery bypass graft (CABG) surgery. The surgery involves grafting a blood vessel-often a vein-to an atherosclerotic

Read the full 1346 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers